Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages.

Abstract

Our previous work demonstrated that hypoxia decreases transcription of the human prostaglandin H synthase-2 (PGHS-2) gene during exposure to lipopolysaccharide (LPS), resulting in decreased prostaglandin E2 (PGE2) synthesis (J. Biol. Chem. 269:32979-32984, 1994). Because PGE2 is reported to inhibit interleukin 1 (IL-1) and tumor necrosis factor (TNF), it is likely that hypoxia, through changes in PGE2, will alter IL-1 and TNF release from the human alveolar macrophage. In addition, like PGHS-2, the TNF and IL-1 promoters contain oxidant-sensitive elements which might be altered by hypoxia. Therefore, we hypothesized that LPS-induced release of TNF and IL-1 would be altered by hypoxia. To test this, human alveolar macrophages were cultured for 24 h with 0 to 1 microgram/ml LPS in a room-air incubator with 5% CO2 or a hypoxia incubator continuously perfused with 5% CO2/95% N2 (O2 < 0.05%). With room air, LPS increased IL-1 beta mRNA and increased IL-1 beta protein release into the culture medium in a dose-dependent manner. Hypoxia increased the LPS-stimulated release of IL-1 beta 30% above that of room-air controls. However, immunoblots showed that hypoxia caused no change in intracellular IL-1 beta compared with room-air controls. There was also no change in LPS-induced IL-1 beta message with hypoxia. The inhibitor of IL-1, IL-1RA, was apparently decreased by hypoxia, but this decrease was not statistically significant. TNF-alpha mRNA and release of protein also increased during LPS exposure in room air. Hypoxia markedly increased LPS-induced TNF-alpha message and release of TNF-alpha compared with LPS-exposed room-air controls. Consistent with our prior observations, hypoxia decreased LPS-induced PGHS-2 message and protein, and also the PGHS-2 product, PGE2. Because PGE2 is reported to inhibit the expression of IL-1 and TNF genes, we inhibited PGE2 synthesis with indomethacin during culture in room air; the result was an increase in the release of IL-1 and TNF. In additional studies, adding PGE2 inhibited TNF release from the hypoxia cells to values near those of room-air controls. In summary, hypoxia increases the release of the cytokines IL-1 beta and TNF-alpha. This increase may be due to decreased PGE2 synthesis during hypoxia. These results demonstrate that the response of the human alveolar macrophage to hypoxia is complex. Hypoxia increases the LPS-stimulated release of the inflammatory cytokines IL-1 and TNF, whereas synthesis of PGHS-2, which generates the anti-inflammatory prostaglandin PGE2 is decreased.

Prevalence and consequences of nutritional depletion in lung transplant candidates

“…Hypoxaemia per se modifies muscle mass through a sharp decline in protein synthesis so that oxygen supply can adapt to demand [18]. Hypoxaemia may also act through a release of pro-inflammatory cytokines [19]. An important factor related to nutritional depletion is the level of systemic inflammation [20,21].…”

Macrophage migration and gene expression in response to tumor hypoxia

“…Hypoxia-induced secretion of proinflammatory cytokines, TNF-a and IL-1, has been found in human alveolar macrophages, blood monocytes and human monocytic cell lines. [73][74][75] Since these proinflammatory cytokines can themselves stimulate VEGF production, 76,77 TNF-a and IL-1 may serve to perpetuate the proangiogenic cytokine milieu in hypoxic areas. Other notable cytokines that appear to be upregulated by hypoxic macrophages include macrophage inhibitory factor (MIF) a cytokine known to be involved in facilitating growth factor-induced tumor and endothelial cell proliferation; 78 and interleukin-18 binding protein, which is known to inactivate the angiostatic factor, interleukin-18.…”

Acute Hypoxia Activates the Neuroimmune System, Which Diabetes Exacerbates

“…Individuals with sleep apnea show increased circulating markers of oxidative stress and inflammation (Montplaisir et al, 1992). In addition, hypoxia causes macrophages to elaborate proinflammatory cytokines, especially IL-1␤ (Hempel et al, 1996), and hypoxia boosts microglial expression of IL-1␤ (Kim et al, 2003).…”